Literature DB >> 17408463

The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders.

William G Morice1, Dragan Jevremovic, Curtis A Hanson.   

Abstract

Granzyme M (GrM) is a novel cytotoxic protein normally exclusively expressed by natural killer (NK)-cells and cytotoxic T-cells with innate immune function. As most T-cell granular lymphocytic leukaemias (T-LGL) are thought to be derived from the adaptive immune system it was predicted that T-LGL would be GrM negative. Contrary to this hypothesis, bone marrow biopsy immunohistochemistry revealed that GrM was frequently expressed in both T-LGL (16 / 18) and NK-LGL (6 / 9). These unexpected results suggest commonality between T- and NK-LGL, providing further support to the notion that T-LGL is a disorder of dysregulated, chronically stimulated, adaptive cytotoxic T-cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408463     DOI: 10.1111/j.1365-2141.2007.06564.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

Review 2.  Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis.

Authors:  Katharine B Moosic; Kusuma Ananth; Felipe Andrade; David J Feith; Erika Darrah; Thomas P Loughran
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

Review 3.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

4.  T-Cell Large Granular Lymphocyte Leukemia: An Interdisciplinary Issue?

Authors:  Johanna Schreiber; Alexander Pichler; Christoph Kornauth; Hannes Kaufmann; Philipp B Staber; Georg Hopfinger
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

Review 5.  Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy.

Authors:  Manali Singh; Kuldeep Jayant; Dipti Singh; Shivani Bhutani; Nitesh Kumar Poddar; Anis Ahmad Chaudhary; Salah-Ud-Din Khan; Mohd Adnan; Arif Jamal Siddiqui; Md Imtaiyaz Hassan; Faez Iqbal Khan; Dakun Lai; Shahanavaj Khan
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

6.  A case of CD4(+)T-cell large granular lymphocytic leukemia.

Authors:  Jaewook Kim; Chan Jeoung Park; Seongsoo Jang; Young-Uk Cho; Sang Hyuk Park; Eul-Ju Seo; Hyun-Sook Chi; Cheolwon Suh
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

7.  Transcriptional signatures of Itk-deficient CD3+, CD4+ and CD8+ T-cells.

Authors:  K Emelie M Blomberg; Nicole Boucheron; Jessica M Lindvall; Liang Yu; Julia Raberger; Anna Berglöf; Wilfried Ellmeier; Ci Edvard Smith
Journal:  BMC Genomics       Date:  2009-05-18       Impact factor: 3.969

Review 8.  COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response.

Authors:  Sanchit Seth; Jyotsna Batra; Srilakshmi Srinivasan
Journal:  Front Mol Biosci       Date:  2020-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.